Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term camptothecin. Found 5 abstracts

Stevenson JP, DeMaria D, Sludden J, Kaye SB, Paz-Ares L, Grochow LB, McDonald A, Selinger K, Wissel P, O'Dwyer PJ, Twelves C. Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. Annals of Oncology. 1999 Mar;10(3):339-44.
Hudes GR, Kosierowski R, Greenberg R, Ramsey HE, Fox SC, Ozols RF, McAleer CA, Giantonio BJ. Phase II study of topotecan in metastatic hormone-refractory prostate cancer. Investigational New Drugs. 1995 Jan;13(3):235-40.
Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, Odwyer PJ. Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas. Investigational New Drugs. 1995 Jan;13(4):347-54.
Haas NB, Lacreta FP, Walczak J, Hudes GR, Brennan JM, Ozols RF, Odwyer PJ. Phase-I Pharmacokinetic Study of Topotecan by 24-Hour Continuous-Infusion Weekly. Cancer Research. 1994 Mar;54(5):1220-6.
Odwyer PJ, Lacreta FP, Haas NB, Halbherr T, Frucht H, Goosenberg E, Yao KS. Clinical, Pharmacokinetic and Biological Studies of Topotecan. Cancer Chemotherapy and Pharmacology. 1994 Aug;34:S46-S52.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term camptothecin

Last updated on Thursday, April 02, 2020